Insider Cluster (2 insiders) ·Filed Apr 24, 2026
Insider cluster: 2 insiders, $22K total
Actionable Insight • Neutral
No actionable signal, the cluster is too small to indicate any material change. Monitor for any future 8-K filings (e.g., clinical trial results) that could affect the stock, and watch for larger insider activity exceeding 0.1% of market cap.
CGEN drugs
CGEN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60Entry
$3.10
T+0 close · Apr 23, 2026 · via day close
Latest settled
−19.68%
T+60 · $2.49
Vs SPY
−24.76%
α at T+60
Horizons
All settled
through T+60
- T+0 · Apr 24 $3.10entry
- T+1 · 7mo ago −5.81%α −5.97% · $2.92
- T+5 · 7mo ago −14.19%α −15.10% · $2.66
- T+20 · 6mo ago −15.81%α −19.83% · $2.61
- T+60 · 4mo ago −19.68%α −24.76% · $2.49
Price Chart
REPLAYWatch the reaction play outLoading chart...
How similar events traded
Executive Summary
Two insiders at Compugen (CGEN) sold shares totaling ~$22K after exercising stock options. The dollar amount represents less than 0.01% of market cap, making this a routine and immaterial cluster.
Key Financial Metrics
Direction
selling
Total Value
$22.4K
Insiders
2
Key Facts
- CEO Ophir Eran sold 5,000 shares at $3.20 for $16,001 after exercising 5,000 options at $0.83 per share.
- SVP Zurit Levine sold 2,000 shares at $3.20 for $6,400 after exercising 4,000 options (2,000 at $0 and 2,000 at $1.15).
- Total open-market sales: $22,401, which is 0.0076% of Compugen's $293M market cap.
- All trades occurred on the same day (April 24, 2026) and appear to be tax-related or cash-out after option exercises.
Financial Impact
$22,401 in total insider sales (negligible relative to $293M market cap)
Risk Factors
- Routine insider sales, no material risk identified.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CGEN-1777320222214 |
Track record
9 reports on CGEN
Filters
- Nov 9, 20267d ago 6-K Neutral 4/10 Entry $2.14 Now $2.04 −4.67% settles Dec 8
- Aug 3, 202615w ago 6-K Neutral 2/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Aug 3, 202615w ago 6-K Neutral 4/10 Entry $2.38 to $2.56 Now $2.04 −14.29% ▲ +7.56% +6.33% vs SPY
- Jun 9, 202623w ago EFFECT Neutral 3/10 Entry $2.02 to $2.39 Now $2.04 +0.99% ▲ +18.32% +16.87% vs SPY
- May 18, 202626w ago 6-K Neutral 4/10 Entry $2.86 to $2.03 Now $2.04 −28.67% ▼ −29.02% −30.60% vs SPY
- Apr 24, 202629w ago Insider Cluster Neutral 2/10 Viewing Entry $3.10 to $2.61 Now $2.04 −34.19% ▼ −15.81% −19.83% vs SPY
- Apr 14, 202631w ago Insider Cluster Neutral 2/10 Entry $2.88 to $2.87 Now $2.04 −29.17% ▼ −0.35% −6.64% vs SPY
- Apr 13, 202631w ago 144 Neutral 3/10 Entry $2.76 to $2.87 Now $2.04 −26.09% ▲ +3.99% −3.74% vs SPY
- Mar 26, 202633w ago Insider Cluster Neutral 3/10 Entry $2.06 to $3.10 Now $2.04 −0.97% ▲ +50.49% +39.82% vs SPY
Showing 9 of 9
US Market Status
Market Closed · Opens in 6h 40m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers